Dr Glenn Rory Faust, MD | |
2201 Hempstead Tpke, East Meadow, NY 11554-1859 | |
(516) 572-6705 | |
(516) 572-5140 |
Full Name | Dr Glenn Rory Faust |
---|---|
Gender | Male |
Speciality | General Practice |
Experience | 38 Years |
Location | 2201 Hempstead Tpke, East Meadow, New York |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003986456 | NPI | - | NPPES |
01363560 | Medicaid | NY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0129X | Surgery - Vascular Surgery | 180968 (New York) | Primary |
Entity Name | Nassau Health Care Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902822992 PECOS PAC ID: 2961315221 Enrollment ID: O20040619000043 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Staten Island Medical Of New York, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669888277 PECOS PAC ID: 4486973690 Enrollment ID: O20150508001480 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Marble Hill Medical Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962868687 PECOS PAC ID: 2769773860 Enrollment ID: O20160621001100 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | St Nicholas Medical Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1316471352 PECOS PAC ID: 1557628047 Enrollment ID: O20171208002582 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Starrett City Medical Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043752785 PECOS PAC ID: 7113288564 Enrollment ID: O20180227000669 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Pelham Pkwy Medical Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285156067 PECOS PAC ID: 4082976386 Enrollment ID: O20180327000712 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | St Nicholas Professional Medical Services Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033631064 PECOS PAC ID: 7618231457 Enrollment ID: O20180503001031 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Pelham Pkwy Professional Medical Services Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063926962 PECOS PAC ID: 9335404557 Enrollment ID: O20180517001134 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Foxhurst Medical Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730547522 PECOS PAC ID: 6901151778 Enrollment ID: O20180619001805 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Bushwick Medical Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1720565922 PECOS PAC ID: 5092068262 Enrollment ID: O20181106000485 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Bushwick Professional Medical Services Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003393299 PECOS PAC ID: 0648516617 Enrollment ID: O20190111001240 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Entity Name | Fordham Medical Of New York Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205332905 PECOS PAC ID: 4284972621 Enrollment ID: O20190211002377 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Glenn Rory Faust, MD 2201 Hempstead Tpke, East Meadow, NY 11554-1859 Ph: (516) 572-6705 | Dr Glenn Rory Faust, MD 2201 Hempstead Tpke, East Meadow, NY 11554-1859 Ph: (516) 572-6705 |
News Archive
Women with the deadliest and rarest form of breast cancer now have a chance of treatment where once their options were severely limited, thanks to a new discovery by George Mason University researchers.
Metabolon, Inc., the leader in global metabolism through biomarker discovery and analysis, today announced that it was awarded US Patent 7,635,556 "Methods for Drug Discovery, Disease Treatment and Diagnosis Using Metabolomics" by the United States Patent and Trademark Office on December 22, 2009.
GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.
A Republican proposal to retain solvency in a key state health care fund is making headway at the Capitol, despite the tumultuous ride reform has taken this session. The fund — which supports MinnesotaCare, a state-sponsored program for about 140,000 "working poor" residents — is set to run a $150 million deficit by 2013.
Findings from a small prospective study suggest that androgen receptor V7 (or AR-V7) status does not significantly affect response to taxane chemotherapy in men with metastatic castration-resistant prostate cancer (mCRPC). Treatment outcomes were largely similar for the 17 patients with AR-V7-positive prostate cancer and the 20 patients with AR-V7-negative disease included in this analysis.
› Verified 5 days ago
Dr. Milos Buhavac, MBBS Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, East Meadow, NY 11554 Phone: 516-572-0123 | |
Dr. Elizabeth Cirincione, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, 8th Floor - Pavillion, East Meadow, NY 11554 Phone: 516-572-6705 Fax: 516-572-5140 | |
Lambros D. George Angus, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, 8th Floor - Pavillion, East Meadow, NY 11554 Phone: 516-572-6705 | |
Jose Filiberto Poveda, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2201 Hempstead Tpke, East Meadow, NY 11554 Phone: 516-572-6434 Fax: 516-572-5465 | |
Dr. Vishes Mehta, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, East Meadow, NY 11554 Phone: 516-572-6132 Fax: 516-572-6153 | |
Leonard Octavius Barrett, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2201 Hempstead Tpke, 8th Floor - Pavillion, East Meadow, NY 11554 Phone: 516-572-6705 Fax: 516-572-5140 |